Sub-acute toxicity and effect of Hwangryunhaedok-tang on human drug-metabolizing enzymes |
Jin, Seong Eun
(K-herb Research Center, Korea Institute of Oriental Medicine)
Lee, Mee-Young (K-herb Research Center, Korea Institute of Oriental Medicine) Seo, Chang-Seob (K-herb Research Center, Korea Institute of Oriental Medicine) Shin, Hyeun-Kyoo (K-herb Research Center, Korea Institute of Oriental Medicine) Cho, Jae-Woo (Pathology Research Center, Korea Institute of Toxicology) Ha, Hyekyung (K-herb Research Center, Korea Institute of Oriental Medicine) |
1 | Kang JJ, Chen YC, Kuo WC, Chen T, Cheng YW, Kuo ML, et al. Modulation of microsomal cytochrome P450 by Scutellariae Radix and Gentianae scabrae Radix in rat liver. Am J Chin Med. 1996;24(1):19-29. DOI |
2 | Ma T, Huang C, Zong G, Zha D, Meng X, Li J, et al. Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis. J Pharm Pharmacol. 2011;63(4):587-93. DOI |
3 | Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012;68(2):213-7. DOI |
4 | Firenzuoli F, Gori L. Herbal medicine today: clinical and research issues. Evid Based Complement Alternat Med. 2007;4(Suppl 1):37-40. DOI |
5 | Moreira DL, Teixeira SS, Monteiro MHD, De-Oliveira ACAX, Paumgartten FJR. Traditional use and safety of herbal medicines. Revista Brasileira de Farmacognosia. 2014;24(2):248-57. DOI |
6 | Nebert DW, Russell DW. Clinical importance of the cytochromes P450. Lancet. 2002;360(9340):1155-62. DOI |
7 | Wienkers LC, Heath TG. Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov. 2005;4(10):825-33. DOI |
8 | Court MH, Hazarika S, Krishnaswamy S, Finel M, Williams JA. Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction. Mol Pharmacol. 2008;74(3):744-54. DOI |
9 | Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, et al. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics. 2005;15(10):677-85. DOI |
10 | Hur J. Donguibogam. Seoul:Namsandang. 2007:382. |
11 | Lu J, Wang JS, Kong LY. Anti-inflammatory effects of Huang-Lian-Jie-Du decoction, its two fractions and four typical compounds. J Ethnopharmacol. 2011;134(3):911-8. DOI |
12 | Marino MR, Vachharajani NN. Drug interactions with irbesartan. Clin Pharmacokinet. 2001;40(8):605-14. DOI |
13 | Ohta Y, Kongo-Nishimura M, Hayashi T, Kishikawa T. Effect of Oren-gedoku-to (Huanglian -Jie-Du-Tang) extract on disruption of hepatic antioxidant defense systems in rats treated with D-galactosamine. J Ethnopharmacol. 2004;94(2-3):323-9. DOI |
14 | Lee MY, Seo CS, Kim YB, Shin IS, Shin HK. Non-clinical safety assessment of Hwangryunhaedok -tang: 13-week toxicity in Crl:CD Sprague Dawley rats. Regul Toxicol Pharmacol. 2014; 68(3):378-86. DOI |
15 | Seo CS, Kim OS, Kim JH, Shin HK. Simultaneous quantification and antiatherosclerosis effect of the traditional Korean medicine, Hwangryunhaedok-tang. BMC Complement Altern Med. 2015;15:108. DOI |
16 | Jin SE, Seo CS, Shin HK, Ha H. Traditional Herbal Formulas to as Treatments for Musculoskeletal Disorders: Their Inhibitory Effects on the Activities of Human Microsomal Cytochrome P450s and UDP-glucuronosyltransferases. Pharmacogn Mag. 2016;12(48):241-52. |
17 | Raymond JR, Yarger WE. Abnormal urine color: differential diagnosis. South Med J. 1988;81(7):837-41. DOI |
18 | Vrba J, Papouskova B, Pyszkova M, Zatloukalova M, Lemr K, Ulrichova J, et al. Metabolism of palmatine by human hepatocytes and recombinant cytochromes P450. J Pharm Biomed Anal. 2015;102:193-8. DOI |
19 | Ogu CC, Maxa JL. Drug interactions due to cytochrome P450. Proc (Bayl Univ Med Cent). 2000;13(4):421-3. DOI |
20 | Lee YC, Lee JN, Bae JS, Park YC. Green urine in a patient who received a continuous infusion of propofol. Kor J Anesthesiol. 2009;56:325-7. DOI |
21 | Gonzalez Frank J, Tukey Robert H. Chapter 3, Drug metabolism. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman's the pharmacological basis of therapeutics, 11th ed. New York: McGraw Hill. 2006:71-91. |
22 | Lee SY, Jang H, Lee JY, Ma JY, Oh SJ, Kim SK. Inhibitory effects of Hwang-Ryun-Hae-Dok -Tang on cytochrome P450 in human liver microsomes. Xenobiotica. 2015;45(2):131-8. DOI |
23 | Wang BL, Li Y. Progress of pharmacokinetic interactions and possible mechanisms of botanical medicines-chemical drugs. Chin J Pharmacol Toxicol. 2008;22:237-40. |
24 | Flockhart DA, Oesterheld JR. Cytochrome P450-mediated drug interactions. Child Adolesc Psychiatr Clin N Am. 2000;9(1):43-76. DOI |
25 | Bush TM, Rayburn KS, Holloway SW, Sanchez-Yamamoto DS, Allen BL, Lam T, et al. Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey. Altern Ther Health Med. 2007;13(2):30-5. |
26 | Katoh M, Yoshioka Y, Nakagawa N, Yokoi T. Effects of Japanese herbal medicine, Kampo, on human UGT1A1 activity. Drug Metab Pharmacokinet. 2009;24(3):226-34. DOI |
![]() |